Koers OncoVista Innovative Therapies, Inc. Other OTC
Aandelen
OVIT
US68232J1051
Biotechnologie & Medisch Onderzoek
Omzet 2013 | - | Omzet 2014 | - | Marktkapitalisatie | 1,3 mln. 1,19 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2013 | -1 mln. -920K | Nettowinst (verlies) 2014 | -2 mln. -1,84 mln. | EV/omzet 2013 | - |
Nettoliquiditeiten 2013 | 44,9K 41,32K | Nettoschuld 2014 | 196K 180K | EV/omzet 2014 | - |
K/w-verhouding 2013 |
-0,75
x | K/w-verhouding 2014 |
-0,51
x | Werknemers | - |
Dividendrendement 2013 * |
-
| Dividendrendement 2014 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 74 | 16-08-07 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 74 | 16-08-07 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+41,79% | 54,04 mld. | |
-0,56% | 41,92 mld. | |
+47,19% | 41,96 mld. | |
-7,20% | 28,35 mld. | |
+12,59% | 26,35 mld. | |
-21,51% | 19 mld. | |
+6,92% | 13 mld. | |
+24,91% | 12,19 mld. | |
+29,60% | 12,28 mld. |